僕の薬学の専門分野の一つは、「フラクショナルレーザーアシストと、リポソームを共に利用した皮膚のドラッグデリバリー」についてなのですが、コロナ禍で全く途絶えていた、講演依頼や論文執筆依頼がつい先月ぐらいから復活するようになりました。

ポストコロナではなく、withコロナ時代。

リーダー不在の日本では混迷を極めていますが、海外では普通の社会に戻りつつあるのをひしと感じますね。

日本にはデジタルデバイドというより、マスコミの「英語デバイド」により海外の情報が、正確に伝わっていない印象がありますよ。

日の出まであと少し。

その時に日本に体力が残っていればいいのですが。

Dear author,
We are pleased to announce that Pharmaceutics has received an updated Impact Factor of 6.321, as published in the 2020 Edition of the Journal Citation Reports® (Clarivate), the 5-Year Impact Factor is 6.734. It now ranks 28/275 (Q1) in the ‘Pharmacology & Pharmacy’ category. And now we have launched a Special Issue entitled “Recent Trends on Liposome Technology: From Emerging Synthesis Strategies to Advanced Lipid Nanosystems for Drug Delivery”.
As guest editor of the special issue, I would like to cordially invite you to contribute an article given the depth of your expertise in this field. For more information on the issue, please visit the Special Issue website:
https://www.mdpi.com/…/special_issues/liposome_technology
Papers may be submitted from now until 30 November 2021 as papers will be published on an ongoing basis. Submitted papers should not be under consideration for publication elsewhere. The paper may be either original research or a review. We also encourage authors to send a short abstract or tentative title to us in advance.
Currently, an Article Processing Charges of 2200 CHF (Swiss Francs) applies to papers accepted after peer review. As the *invited* contributor, you will have15% discount (330 CHF) for the submission. In addition, 500 CHF vouchers will apply for early bird submissions (within 2 months from this invitation), and kindly notice it could not use together with the 15% discount.
We hope that you also find this Special Issue interesting and of current importance in the field and we look forward to hearing from you soon.
Kind regards,
＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝
Dear Dr. Takahiro Fujimoto MD, PhD
Greetings! Considering your work regarding
“Transcutaneous drug delivery by liposomes using fractional laser technology”
Transdermal delivery of hydrophilic peptides remains a challenge due to their poor cellular uptake and transdermal penetration. We hypothesize that combination of a CO2 fractional laser to enhance percutaneous absorption and liposomes as transdermal carriers would improve skin penetration of hydrophilic drugs.
we cordially invite you to share your NEW research findings by delivering an oral/poster presentation at the 10th International Conference on Biomedical Engineering and Biotechnology (ICBEB 2021).
Time: November 15-18, 2021
Venue: Suzhou, China/Online via Microsoft TEAMS
Website: www.icbeb.org
If you are not available to present physically, Online Presentation via Microsoft Teams or pre-recorded video presentation is also warmly welcomed. For the pre-recorded video presentations in ICBEB 2020, please go to the homepage of conference website.
If you’re not available for attendance, could you help us review some papers at your convenience? Active reviewers are candidates for Technical Program Committee next year. If yes, please kindly send us your CV or inform us of your research interests, thanks in advance.
It is highly appreciated if you kindly forward this conference information to your colleagues or friends in this field.
Sincerely,
inda Li
ICBEB Conference Committee